United States
Germany
Japan
United Kingdom
China
PPP5C (PP5) mouse monoclonal antibody, clone OTI4G8 (formerly 4G8)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Dog, Mouse, Rat |
Antibodies
PPP5C (PP5) mouse monoclonal antibody, clone OTI5G5 (formerly 5G5)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Dog, Mouse, Rat |
PPP5C (PP5) mouse monoclonal antibody, clone OTI3G1 (formerly 3G1)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
PPP5C (PP5) mouse monoclonal antibody, clone OTI6F1 (formerly 6F1)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
PPP5C (PP5) mouse monoclonal antibody, clone OTI1G2 (formerly 1G2)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
PPP5C (PP5) mouse monoclonal antibody, clone OTI2E12 (formerly 2E12)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
PPP5C (PP5) mouse monoclonal antibody, clone OTI4G8 (formerly 4G8)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Dog, Mouse, Rat |
PPP5C (PP5) mouse monoclonal antibody, clone OTI5G5 (formerly 5G5)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Dog, Mouse, Rat |
Anti-PPP5C (PP5) mouse monoclonal antibody, clone OTI5A8 (formerly 5A8)
| Applications | IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
PPP5C (PP5) mouse monoclonal antibody, clone OTI3G1 (formerly 3G1)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
PPP5C (PP5) mouse monoclonal antibody, clone OTI2G2 (formerly 2G2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Mouse, Rat |
Anti-PPP5C (PP5) mouse monoclonal antibody, clone OTI4E1 (formerly 4E1)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
PPP5C (PP5) mouse monoclonal antibody, clone OTI6F1 (formerly 6F1)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
PPP5C (PP5) mouse monoclonal antibody, clone OTI1G2 (formerly 1G2)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
